[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Hepatitis B |
|
|
Clinical Trial: Peg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected with Genotype 1
This study is currently recruiting patients.
|
Purpose
The objective is to compare the safety and efficacy of the following three treatment regimens in previously untreated adult subjects with chronic hepatitis C infected with Genotype 1: (1) PEG-Intron 1.5 µg/kg/wk in combination with weight based REBETOL (800-1400 mg/day); (2) PEG-Intron 1µg/kg/wk in combination with weight based REBETOL (800-1400 mg/day); and (3) PEGASYS 180 µg/wk plus COPEGUS 1000-1200 mg/day.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Chronic Hepatitis C | Drug: PEG-Intron Plus REBETOL Drug: PEGASYS Plus COPEGUS | Phase III |
MedlinePlus related topics: Hepatitis; Hepatitis C
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Official Title: Comparison of PEG-Intron 1.5µg/kg/wk Plus REBETOL vs PEG-Intron 1µg/kg/wk Plus REBETOL vs PEGASYS 180µg/wk Plus COPEGUS in Previously Untreated Adult Subjects With Chronic Hepatitis C Infected with Genotype 1
Expected Total Enrollment: 2880
Study start: March 2004; Expected completion: July 2006
PEG-Intron Dose: Screening 2 Weight 40-50 kg Volume to Inject (mL)0.22; Screening 2 Weight 51-60 kg Volume to Inject (mL)0.28; Screening 2 Weight 61-75 kg Volume to Inject (mL)0.33; Screening 2 Weight 76-85 kg Volume to Inject (mL)0.41; Screening 2 Weight 86-104 kg Volume to Inject (mL)0.48; Screening 2 Weight 105-125 kg Volume to Inject (mL)0.58 from two vials
REBETOL Dosage (for Use With PEG-INTRON): Screening 2 Weight 40-60 kg Daily Dose 800mg; Screening 2 Weight >65-85 kg Daily Dose 1000mg; Screening 2 Weight >85-105 kg Daily Dose 1200mg; Screening 2 Weight >105-125 kg Daily Dose 1400mg
The PEGASYS dose of 1 mL (180 µg) will be administered once weekly subcutaneously on the same day of the week
COPEGUS Dosage (for Use With PEGASYS): Screening 2 Weight <75kg Daily Dose 1000mg; Screening 2 Weight > or = 75kg Daily Dose 1200mg
NOTE: Double Blind for PEG-Intron; Open Label for REBETOL, PEGASYS and COPEGUS
Eligibility
Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Both
Criteria
INCLUSION CRITERIA:
- Previously untreated adults with chronic hepatitis C (HCV RNA qPCR plasma positive)
- Individuals with HCV genotype 1 (mixed 1a/1b is acceptable)
- Compensated liver disease
- No significant co-existing psychiatric disease
- Historic liver biopsy slides available
- Adults aged 18-70
- Individuals weighing 88-275 pounds (40-125 kg)
- Free from substance abuse for past 2 years
- Those suffering from diabetes and/or hypertension must have normal eye exams and retinal photographs (these will be done as part of the study before hepatitis C treatment is given)
- Patients and partners of patients willing to use adequate contraception during the course of the study
- Hematology laboratory results of: * Hemoglobin (HGB) > 12 g/dL for females or > 13g/dL for males * White Blood Cell Count (WBC) > 3,000 mm3 * Neutrophils > 1,500 mm3 * Platelets > 80,000 mm3
- Chemistry laboratory results of: * Normal Thyroid Stimulating Hormone (TSH), albumin, creatinine, and direct bilirubin * Antinuclear antibody (ANA) < 1:320 * Fasting Glucose 70-140 mg/dL Note: If glucose levels are between 116-140 mg/dL or an individual has diabetes, HbA1C must be < 8.5
EXCLUSION CRITERIA:
- Previous hepatitis C treatment
- Pregnant women or partners of pregnant women
- Patients or partners of patients who intend to become pregnant any time during the 48 weeks
- Women who are breast feeding
- People with liver disease not caused by hepatitis C
- Individuals infected with the hepatitis B virus and/or human immunodeficiency virus (HIV)
- Patients with a history of liver cancer (hepatocellular carcinoma)
- Known blood disorders such as hemoglobinopathy, coagulopathy, or G6PD deficiency
- Body organ transplant
- Any known or suspected cancer within the past 5 years
- Individuals who currently use EPO, G-CSF and/or GM-CSF
- Those having a history of or active clinical gout
- People who have chronic pulmonary disease
- Individuals who have a medical condition that would likely require systemic steroids
- Those with a history of central nervous system (CNS trauma) or seizure disorders
- Current or previous use of lithium or antipsychotic drugs
- Individuals who currently have or show signs of moderate to severe depression
- Patients with clinically significant electrocardiogram (ECG) abnormalities
- Individuals with serious heart problems such as those who have had a heart attack, high blood pressure, or other heart problems
- Patients that weigh > 231-275 pounds (105-125 kg) AND have a body mass index (BMI) > 30 AND have 3 or more of the risk factors below: (a) Strong family history of coronary heart disease (CHD) which includes 2 or more first-degree relatives with CHD or family history of early CHD at age < 55 for male relatives or < 65 for female relatives (b) People with abnormal total cholesterol and/or sub fractions (uncontrolled hypercholesterolemia) (c) Diabetes (d) Hypertension (e) Smoking
Location and Contact Information
Alabama
University of South AL, Mobile, Alabama, 36693, United States; Recruiting
Emilie Barnett 251-660-5553 unknown
Jorge Herrera, Principal Investigator
University of AL at Birmingham Liver Center, Birmingham, Alabama, 35294, United States; Recruiting
Tracey Gwaltney 205-975-5676 tgwaltney@uabmc.edu
Aasim Sheikh, Principal Investigator
Arizona
University of Arizona Liver Research Institute, Tucson, Arizona, 85724, United States; Recruiting
Donna Webb 520-626-3735 dbwebb@u.arizona.edu
Thomas Boyer, Principal Investigator
California
Kaiser Permanente, Sacramento, California, 95825, United States; Recruiting
Gayle Witt 916-973-5782 gayle.witt@kp.org
Mary Pat Pauly, Principal Investigator
VA Medical Center - 11, Long Beach, California, 90822, United States; Recruiting
Marlene St. John 562-826-5933 marlene.stjohn@med.va.gov
Timothy Morgan, Principal Investigator
SCPMG, San Diego, California, 92173, United States; Recruiting
Karen Cloutman 619-528-6550 unknown
Lisa M. Nyberg, Principal Investigator
Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States; Recruiting
Janet Clarke 310-423-2337 clarkej@cshs.org
Fred Poordad, Principal Investigator
University of California Irvine Medical Center, Orange, California, 92868, United States; Recruiting
Namgyal Kyulo 714-456-6925 nkyulo@uci.edu
Ke-Qin Hu, Principal Investigator
University of California, Davis Sacremento Medical Center (UCDMC), Sacramento, California, 95817, United States; Recruiting
Laura Lester 916-734-8694 laura.lester@ucdemc.ucdavis.edu
Lorenzo Rossaro, Principal Investigator
Kaiser Permanente, Santa Clara, California, 95051, United States; Recruiting
Lynne Sugimoto 408-236-4989 unknown
Joanna Ready, Principal Investigator
San Francisco General Hospital, San Francisco, California, 94110, United States; Recruiting
Annie Sharabidze 415-206-4061 asharabidze@meds.fgh.ucsf.edu
Khalili Mandana, Principal Investigator
Southern California Kaiser Permanente Medical Group, San Marcos, California, 92069, United States; Recruiting
Nancy Crowe 619-662-5410 unknown
Anders Nyberg, Principal Investigator
Colorado
South Denver Gastroenterology, PC, Englewood, Colorado, 80110, United States; Recruiting
Lu Antronica 303-788-8888 Ext. 139 unknown
Marcelo Kugelmas, Principal Investigator
Connecticut
Connecticut Gastroenterology & Medical Associates, Hartford, Connecticut, 06106, United States; Recruiting
Michele Wardlaw 610-524-4328 swardla@harthosp.org
Jonathan Israel, Principal Investigator
GI Division UConn Health Center, Farmington, Connecticut, 06030, United States; Recruiting
Martha Schwartz 860-679-3878 unknown
George Wu, Principal Investigator
District of Columbia
Walter Reed Army Medical Center, Washington, District of Columbia, 20307, United States; Recruiting
Brooke Huntley 202-782-6390 brooke.huntley@na.amedd.army.mil
Maria Sjogren, Principal Investigator
Florida
South Florida Center of Gastroenterology, P.A., Wellington, Florida, 33414, United States; Recruiting
Viola Kauthen 561-798-9025 sslctrgi@bellsouth.net
Mitchell Davis, Principal Investigator
Bach and Godofsky, MD PA, Bradenton, Florida, 34205, United States; Recruiting
Michele Mays 941-746-2711 Ext. 24 minursenp@aol.com
Eliot Godofsky, Principal Investigator
Miami Research Associates, Miami, Florida, 33173, United States; Recruiting
Margarita Mederos 305-279-0015 Ext. 4208 lrothman@gicarecenter.com
Lawrence Rothman, Principal Investigator
University of Miami Center for Liver Diseases, Miami, Florida, 33136, United States; Recruiting
Johanna Stamates 305-243-2854 unknown
Eugene Schiff, Principal Investigator
Georgia
Digestive Healthcare of Georgia, PC, Atlanta, Georgia, 30309, United States; Recruiting
Deborah Jewett 404-355-3200 Ext. 158 jewett_deborah@piedmont.org
Raymond Rubin, Principal Investigator
Northwest Georgia Gastroenterology Associates, Marietta, Georgia, 30060, United States; Recruiting
Cathy Maffei 678-819-4237 cathym@nwgagastro.com
Robert Strauss, Principal Investigator
Kaiser Permanente, Atlanta, Georgia, 30328, United States; Recruiting
Jeanine Bernstein 770-677-6261 jeanine.bernstein@kp.org
Christine Bruno, Principal Investigator
Illinois
Northwestern University, Chicago, Illinois, 60611, United States; Recruiting
Kim Sipich 312-469-4168 Kspich@aol.com
Steven Flamm, Principal Investigator
Digestive Health Services, Downers Grove, Illinois, 60515, United States; Recruiting
JoAnn Sandstrom 630-434-9312 unknown
Rockford Yapp, Principal Investigator
Indiana
Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States; Recruiting
Patricia Anderson 317-278-2586 pasander@iupui.edu
Paul Kwo, Principal Investigator
Iowa
VA Medical Center Iowa City, Iowa City, Iowa, 52246-2208, United States; Recruiting
Donna Evans 319-338-0581 Ext. 7699 donna.evans2@med.va.gov
Warren Schmidt, Principal Investigator
Kentucky
University of Kentucky, Lexington, Kentucky, 40536, United States; Recruiting
Karen Meekins 859-323-6423 kmmeek0@uky.edu
Alvaro Koch, Principal Investigator
University of Louisville, HSC, Louisville, Kentucky, 40202, United States; Recruiting
Jackie Stich 502-852-5547 jackie@louisville.edu
Luis Marsano, Principal Investigator
Louisiana
LSU Health Sciences Center, Shreveport, Louisiana, 71130, United States; Recruiting
Dana Favrot 318-675-5902 unknown
John King, Principal Investigator
Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States; Recruiting
Deborah Baudy (504) 842-4985 dbaudy@ochsner.org
Robert Perrillo, Principal Investigator
Louisiana State University, New Orleans, Louisiana, 70115, United States; Recruiting
Rochelle Norman (504) 891-8311 rnorma1@lsuhsc.edu
Luis Balart, Principal Investigator
Tulane University Health Science Center, New Orleans, Louisiana, 70112, United States; Recruiting
Delainna Bartholomew 504-585-6902 delainna.bartholomew@hcahealthcare.com
Shobha Joshi, Principal Investigator
Louisiana State University, Health Sciences Center, Baton Rouge, Louisiana, 70805, United States; Recruiting
Amy Lambert 225-358-1287 anicho@lsuhsc.edu
William Cassidy, Principal Investigator
Maine
Hepatitis Treatment Service, Maine Medical Center, Portland, Maine, 04102, United States; Recruiting
Virginia Field 207-871-2099 Ext. 2 unknown
Alan Kilby, Principal Investigator
Maryland
Johns Hopkins University, Baltimore, Maryland, 21287, United States; Recruiting
Danyelle Rosebrough (410) 614-0454 drosebr1@jhmi.edu
Mark Sulkowski, Principal Investigator
University of Maryland School of Medicine, Baltimore, Maryland, 21201, United States; Recruiting
Rick Leeper 410-706-4601 leeper@umbi.umd.edu
David Oldach, Principal Investigator
Digestive Disease Associates, PA, Baltimore, Maryland, 21229, United States; Recruiting
Ellen Hoverson 410-737-0053 e.hoverson@ddamd.com / s.shahi@ddamd.com
Natarajan Ravendhran, Principal Investigator
Massachusetts
Lahey Clinic Medical Center, Burlington, Massachusetts, 01805, United States; Recruiting
Agnes Trabucco 781-744-5330 agnes.trabucco@lahey.org
Fredric Gordon, Principal Investigator
Boston Medical Center, Boston, Massachusetts, 02118, United States; Recruiting
Tiffany Geahigan 617-632-1072 unknown
Nezam Afdhal, Principal Investigator
Massachusetts General Hospital, Boston, Massachusetts, 02114, United States; Recruiting
Rebecca Nuzzo 617-724-3836 rnuzzo1@PARTNERS.ORG
Raymond Chung, Principal Investigator
Michigan
Henry Ford Hospital, Detroit, Michigan, 48202, United States; Recruiting
Anna Leyson-Fiel 313-916-3369 Aleyson1@hfhs.org
Kimberly A. Brown, Principal Investigator
William Beaumont Hospital, Royal Oaks, Michigan, 48073, United States; Terminated
Minnesota
Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States; Recruiting
Patricia Wanzek 612-347-7683 tricia@123mail.net
Craig Peine, Principal Investigator
Minnesota Clinical Research Center, Plymouth, Minnesota, 55443, United States; Recruiting
Janet Walters 612-870-5596 jwalters@mngastro.com
Coleman Smith, Principal Investigator
VA Medical Center, Minneapolis, Minnesota, 55417, United States; Recruiting
Lori Tetrick 612-467-4149 lori.tetrick@med.va.gov
Samuel Ho, Principal Investigator
Mayo Clinic, Rochester, Minnesota, 55905, United States; Recruiting
Stephanie Johnson 507-284-9709 unknown
John Gross, Principal Investigator
Missouri
VA Medical Center, Kansas City, Missouri, 64128, United States; Recruiting
Karen Luken 816-861-4700 karen.luken@med.va.gov
Prashant Pandya, Principal Investigator
St. Louis University, St. Louis, Missouri, 36110, United States; Recruiting
Judy Thompson 314-977-9388 rauscher@slu.edu
Bruce Bacon, Principal Investigator
University of Missouri-Columbia, Columbia, Missouri, 65212, United States; Terminated
Bradley Freilich, M.D., LLC, Kansas City, Missouri, 64131, United States; Recruiting
Erin Downs 816-361-0055 unknown
Bradley Freilich, Principal Investigator
Washington University School of Medicine, St. Louis, Missouri, 63110, United States; Recruiting
Janet Riley 314-454-8160 unknown
Jeffrey Crippin, Principal Investigator
Mercy St. John's, Springfield, Missouri, 65804, United States; Recruiting
Kelly Weaver 417-889-6674 Ext. 264 kweaver@sprg.mercy.net
Allan Weston, Principal Investigator
Nebraska
Gastroenterology Specialists, PC, Lincoln, Nebraska, 68503, United States; Recruiting
Janet Griffin 402-465-4545 unknown
Douglas Dalke, Principal Investigator
University of Nebraska Medical Center, Omaha, Nebraska, 68198-2000, United States; Recruiting
Mary Capadano (402) 559-3652 mcapadano@unmc.edu
Mark Malliard, Principal Investigator
New Jersey
Affiliates in Gastroenterology, PA, Florham Park, New Jersey, 07932, United States; Recruiting
Donna J Fanelli 973-410-1800 Ext. 19 unknown
Lawrence Stein, Principal Investigator
New York
North Shore University Hospital, Manhasset, New York, 11030, United States; Recruiting
Maly Tiev 516-562-1364 mchhua@nshs.edu
David Bernstein, Principal Investigator
University Hospital-SUNY Upstate Medical University, Syracuse, New York, 13210, United States; Recruiting
Karyn Kushner 315-464-5794 kushnerk@upstate.edu
Robert Levine, Principal Investigator
Bronx VA Medical Center, Bronx, New York, 10468, United States; Recruiting
Norbert Brau, Principal Investigator
VA New York Harbor Healthcare System, New York, New York, 10010, United States; Recruiting
Stanley John 212-686-7500 Ext. 4477 stanley.john@med.va.gov
Edmund Bini, Principal Investigator
Weill Medical College of Cornell University, New York, New York, 10021, United States; Recruiting
Piali Samanta 212-746-2114 pms2002@med.cornell.edu
Ira Jacobson, Principal Investigator
Beth Israel Medical Center, New York, New York, 10003, United States; Recruiting
Dave Latorre 212-420-4034 dlatorre@chpnet.org
David Clain, Principal Investigator
New York Medical College, Valhalla, New York, 10595, United States; Recruiting
Ana Casellas 914-594-3439 ana_casellas@nymc.edu
Edward Lebovics, Principal Investigator
Huntington Medical Group, Huntington, New York, 11746, United States; Recruiting
Mount Sinai Medical Center, New York, New York, 10029, United States; Recruiting
Debora Goldman 212-241-2060 debora.goldman@msnyuhealth.org
Efsevia Albanis, Principal Investigator
Columbia Presbyterian Medical Center, New York, New York, 10032, United States; Recruiting
Kate McLean 212-305-3839 kcm2103@columbia.edu
Robert Brown, Principal Investigator
North Carolina
Duke University Medical School, Durham, North Carolina, 27710, United States; Recruiting
Patricia Bixby 919-681-6819 bixby001@mc.duke.edu
John McHutchison, Principal Investigator
Carolina Center for Liver Disease, Charlotte, North Carolina, 28203, United States; Recruiting
Heather Roberts 704-524-5478 Ext. 108 hroberts@ccldhepatology.com
Robert Reindollar, Principal Investigator
Ohio
University of Cincinnati, Cincinnati, Ohio, 45267, United States; Recruiting
Susan Sibert 513-584-2363 unknown
Kenneth Sherman, Principal Investigator
Summa Health System, Akron, Ohio, 44304, United States; Recruiting
Hector Bonilla, Principal Investigator
University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States; Recruiting
Madeleine Murphy 216-844-5379 madeleine.murphy@uhhs.com
Anthony Post, Principal Investigator
Oregon
Oregon Health Sciences University, Portland, Oregon, 97201, United States; Recruiting
Renee Rutledge 503-494-0876 rutledgr@ohsu.edu
Atif Zaman, Principal Investigator
Pennsylvania
Regional Gastroenterology Associates of Lancaster, Lancaster, Pennsylvania, 17603, United States; Recruiting
Margaret Porter 717-544-3404 porter@rgal.com
Alexandra Gibas, Principal Investigator
Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States; Recruiting
Deborah Moretti 215-955-5247 unknown
Steven Herrine, Principal Investigator
Pennsylvania Hospital, Philadelphia, Pennsylvania, 19107, United States; Recruiting
Frederick Nunes, Principal Investigator
Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States; Recruiting
Laurie Peiffer (717) 531-8259 lpeiffer@psu.edu
Thomas McGarrity, Principal Investigator
Temple University Hospital, Philadelphia, Pennsylvania, 19140, United States; Recruiting
Monika Burke 215-707-3434 unknown
Martin Black, Principal Investigator
Albert Einstein Medical Center, Philadelphia, Pennsylvania, 19141, United States; Recruiting
Donna McGill 215-456-3376 jakemand@einstein.edu
Santiago Munoz, Principal Investigator
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States; Recruiting
Trudy Cross 412-802-3158 unknown
Mordechai Rabinovitz, Principal Investigator
Drexel University College of Medicine, Philadelphia, Pennsylvania, 19103, United States; Recruiting
Tammy McKay 215-762-3900 unknown
Gillian Zeldin, Principal Investigator
Rhode Island
University Gastroenterology, Providence, Rhode Island, 02905, United States; Recruiting
Brandie Milovitsch 401-421-8800 unknown
Thomas Sepe, Principal Investigator
South Carolina
Medical University of South Carolina, Charleston, South Carolina, 29425, United States; Recruiting
Nancy Huntley 843-792-6901 unknown
Adrian Reuben, Principal Investigator
Tennessee
Premier Quality Research Consultants, Nashville, Tennessee, 37211, United States; Recruiting
Cindy Drolsum 615-832-5530 unknown
Robert Herring, Principal Investigator
Texas
The Liver Institute at Methodist Dallas, Dallas, Texas, 75208, United States; Recruiting
Devin Holt 214-947-4419 devinholt@mhd.com
Reem Ghalib, Principal Investigator
Alamo Medical Research, San Antonio, Texas, 78215, United States; Recruiting
Michael France 210-253-3422 mfrance@alamomedicalresearch.com
Eric Lawitz, Principal Investigator
University of Texas, Dallas, Texas, 75390, United States; Recruiting
Rivka Elbein 214-648-4811 Rivka.Elbein@UTSouthwestern.edu
William Lee, Principal Investigator
Liver Specialists of Texas, P.A., Houston, Texas, 77030, United States; Recruiting
Wen Tung 713-794-0700 lstwen@sbcglobal.net
Joseph Galati, Principal Investigator
Kelsey-Seybold Clinic, Houston, Texas, 77025, United States; Recruiting
Jennifer Marel 713-442-1212 jsmarvel@kelsey-seybold.com
Greg Wayne Galler, Principal Investigator
Utah
Mountain West Gastroenterology, Salt Lake City, Utah, 84121, United States; Recruiting
Amanda McCaffrey 801-944-3165 unknown
Terry Box, Principal Investigator
Vermont
University Of Vermont, Burlington, Vermont, 05405, United States; Recruiting
Mary Ann Ray 802-847-8215 unknown
Edward Krawitt, Principal Investigator
Virginia
University of Virginia, Dept. of GI/Hepatology, Charlottesville, Virginia, 22908, United States; Terminated
Mount Vernon Endoscopy Center, Alexandria, Virginia, 22306, United States; Recruiting
Bonnie McCone 703-780-0994 unknown
Jonathan McCone, Principal Investigator
Digestive & Liver Disease Specialists, Norfolk, Virginia, 23502, United States; Recruiting
Rebecca Mosconi 757-466-0165 Ext. 29 beckym@dlds.org
Michael Ryan, Principal Investigator
Medical College Of Virginia, Richmond, Virginia, 23298, United States; Recruiting
Carolyn Frey 804 828 9163 Carolyn.Frey@med.va.gov
Mitchell Shiffman, Principal Investigator
Kaiser Permanente Medical Center, Falls Church, Virginia, 22046, United States; Recruiting
Sally Makay 703-531-1661 sally.j.makay@kp.org
Robert Sjogren, Principal Investigator
Wisconsin
Dean Medical Center, Madison, Wisconsin, 53715, United States; Recruiting
Leana Guelzow 608-252-7406 leana.guelzow@deancare.com
James Levin, Principal Investigator
Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, 53226, United States; Recruiting
Sheila Thierfelder 414-259-3823 sthierf@mcw.edu
Jose Franco, Principal Investigator
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, 53792-5124, United States; Recruiting
Kathy Massoth 608-263-4185 kmm@medicine.wisc.edu
Michael Lucey, Principal Investigator
More Information
http://www.idealstudy.com
Record last reviewed: March 2005
Last Updated: March 31, 2005
Record first received: April 20, 2004
ClinicalTrials.gov Identifier: NCT00081770
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Add Hepatitis B Vaccination to Your Back to School List (National Center for Infectious Diseases, CDC, OPHS, HHS)
- Advice for Parents (Hepatitis B Foundation)

Not Signed In -


